CN Patent

CN117693335A — 组合治疗方法

Assigned to Ross Research Center LLC · Expires 2024-03-12 · 2y expired

What this patent protects

本文提供了使用安非他酮和/或其代谢物和唑尼沙胺或其它类似的抗惊厥药或GABA能药，任选地进一步与一种或多种尼古丁替代或取代产品组合的组合治疗方法，用于促进戒烟、减少对可燃烟草产品的渴望，治疗与可燃烟草产品相关的依赖、成瘾或戒断，和/或促使吸烟者从可燃烟草产品转换为尼古丁替代或取代产品，诸如电子烟。

USPTO Abstract

本文提供了使用安非他酮和/或其代谢物和唑尼沙胺或其它类似的抗惊厥药或GABA能药，任选地进一步与一种或多种尼古丁替代或取代产品组合的组合治疗方法，用于促进戒烟、减少对可燃烟草产品的渴望，治疗与可燃烟草产品相关的依赖、成瘾或戒断，和/或促使吸烟者从可燃烟草产品转换为尼古丁替代或取代产品，诸如电子烟。

Drugs covered by this patent

Patent Metadata

Patent number: CN117693335A
Jurisdiction: CN
Classification: —
Expires: 2024-03-12
Drug substance claim: No
Drug product claim: No
Assignee: Ross Research Center LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.